Elixinol’s focus in its latest update was its “highly value-accretive” acquisition of leading German hemp-derived CBD player, CannaCare Health.
The first quarter of the calendar year is traditionally softer for retail, while consumers curb discretionary spend after Christmas and holiday trading periods.
The Elixinol share price has been a relatively steady faller since a very short-lived high of 47 cents a share in May 2020.
We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you.
This Service provides only general, and not personalised financial advice, and has not taken your personal circumstances into account.